Common Stock and Stock Options | Note 4. Common Stock and Stock Options Stock Based Compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Non cash stock based compensation expense was $32,765 and $40,941 for the three months ended September 30, 2019 and 2018, respectively. Non cash stock based compensation expense was $98,301 and $83,960 for the nine months ended September 30, 2019 and 2018, respectively. Unrecognized compensation expense was $17,473 as of September 30, 2019 and will be recognized through 2023. There was no tax benefit recorded for this compensation cost as the expense relates to incentive stock options that do not qualify for a tax deduction until, and only if, a qualifying disposition occurs. The non-employee Board members received compensation of 35,725 and 52,487 aggregate shares of common stock of the Company during the nine months ended September 30, 2019 and 2018, respectively. The stock had an aggregate value of $89,995 and $73,379 for the nine months ended September 30, 2019 and 2018, respectively, and was recorded as non-cash stock compensation expense in the financial statements. The cumulative status of options granted and outstanding at September 30, 2019, and December 31, 2018, as well as options which became exercisable in connection with the Company’s stock option plans is summarized as follows: Employee Stock Options Weighted Average Stock Options Exercise Price Outstanding at January 1, 2018 381,447 $ 4.54 Granted 41,719 1.25 Exercised (21,225) 0.84 Expired (5,000) 3.10 Outstanding at December 31, 2018 396,941 $ 4.41 Exercised (31,788) 0.84 Expired (271,500) 6.00 Forfeited (17,616) 1.00 Outstanding at September 30, 2019 76,037 $ 1.03 Options exercisable at December 31, 2018 329,988 $ 5.09 Options exercisable at September 30, 2019 33,643 $ 0.92 During the nine months ended September 30, 2019, a total of 31,788 stock options were exercised. The Company’s new President, Mr. Jeremy Young, received a loan from the Company in the amount of $14,952 in February 2019 to enable him to exercise 17,800 stock options. Per a Promissory Note signed by Mr. Young this loan is to be repaid in two installments with the final installment due January 1, 2020. The first installment of $7,475 was repaid in February 2019 and the balance is recorded on the balance sheet as a Note Receivable as of September 30, 2019. Exercise prices for options ranged from $0.84 to $1.25 at September 30, 2019. The weighted average option price for all options outstanding at September 30, 2019, was $1.03 with a weighted average remaining contractual life of 6.7 years. There were no non-employee director stock options outstanding during 2019 and 2018. |